Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Cardiac assist devices are used to support the failing heart which cannot be managed with standard medical therapy. Mechanical Circulatory Support devices are devices which replace or assist the pumping function of the ventricles. GlobalData uses proprietary data and analytics to provide a comprehensive report on the mechanical circulatory support devices devices market, including market shares of different players within Australia. Buy the latest report here.

Smarter leaders trust GlobalData

In 2021, GlobalData’s Market Model methodology determined that the leading player in the mechanical circulatory support devices market in Australia was Abbott Laboratories followed by Medtronic and Syncardia Systems.

Mechanical Circulatory Support devices support the functioning of a weak heart by pumping blood. They can be used as a bridge to transplantation, for destination therapy, or as a bridge to recovery postcardiotomy. External Ventricular Assist Devices, Left Ventricular Assist Devices and Total Artificial Heart are tracked in this segment. Extracorporeal membrane oxygenators and percutaneous devices are not covered here. An external/paracorporeal ventricular assist device is the device which has a pump placed outside the body. An implantable left ventricular assist device is a ventricular assist system intended for the treatment of end-stage heart failure. A Total Artificial Heart is a prosthetic device that is implanted into the body to replace the biological heart.

Following the widespread disruption resulting from the COVID-19 pandemic to the broader medical devices market during 2020 and 2021, the value of the mechanical circulatory support devices devices market within Australia was expected to be over $1m in 2021.

For the latest complete market share analysis of mechanical circulatory support devices device market in Australia, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.